Laquinimod Appears Effective Against Multiple Sclerosis

This article originally appeared here.
Share this content:
Laquinimod Appears Effective Against Multiple Sclerosis
Laquinimod Appears Effective Against Multiple Sclerosis

THURSDAY, Sept. 22, 2016 (HealthDay News) -- An experimental drug, laquinimod, appears to prevent or slow the progression of multiple sclerosis (MS) in mice, according to a study published online Sept. 21 in Neurology: Neuroimmunology & Neuroinflammation.

Scott Zamvil, M.D., Ph.D., of the University of California, San Francisco, and colleagues used 50 mice bred to develop a spontaneous form of MS. The mice received either a daily dose of oral laquinimod, or a placebo. The investigators then analyzed and counted the rodents' T cells and B cells.

Only 29 percent of the mice taking laquinimod developed MS compared to 58 percent of those given the placebo. The researchers believe that the drug may help prevent MS, since there was a 96 percent reduction in harmful clusters of B cells.

In a second experiment that involved 22 mice, Zamvil's group gave the animals laquinimod after they had experienced some MS-linked paralysis. The disease progression among the mice slowed significantly as a result, the researchers found.

Several authors disclosed financial ties to pharmaceutical companies, including Teva, which manufactures laquinimod and provided the drug for the study.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Automated Central System Offers Time Savings for Pharmacists

Automated Central System Offers Time Savings for Pharmacists

Cart-fill process using new automated system is more efficient, frees up time for other roles

Therapeutic Horseback Riding Can Help Alleviate PTSD in Veterans

Therapeutic Horseback Riding Can Help Alleviate PTSD in ...

Study found statistically and clinically significant reduction in PTSD scores after six weeks of THR

Bariatric Surgery Linked to Discontinuing Diabetes Meds

Bariatric Surgery Linked to Discontinuing Diabetes Meds

Six-year antidiabetes treatment initiation rate also much lower after bariatric surgery

is free, fast, and customized just for you!

Already a member?

Sign In Now »